Physician profile
Madeline C Fields
NPI 1962667360
$5,451.80
in general payments reported to CMS, 2019-2025
14 companies · $820 in 2025
The $820 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,133 · 2020: $282 · 2021: $115 · 2022: $65.85 · 2023: $499 · 2024: $537 · 2025: $820.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,855.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $1,786.65 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $1,158.57 | 2019-2020 | |
| Ucb, INC. | $715.70 | 2019-2025 | Briviact, Fintepla, Nayzilam |
| Sk Life Science, INC. | $446.27 | 2023-2025 | |
| Greenwich Biosciences, INC. | $392.38 | 2019 | |
| Neurelis, INC. | $343.73 | 2023-2025 | Valtoco |
| Livanova USA, INC. | $203.09 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Leica Microsystems INC. | $148.70 | 2019-2025 | Mammotome Elite |
| Aquestive Therapeutics, INC. | $83.55 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $62.94 | 2019 | |
| Acadia Pharmaceuticals INC | $35.28 | 2025 | Daybue |
| Aucta Pharmaceuticals, INC. | $33.30 | 2025 | Motpoly Xr |
| Medtronic USA, INC. | $26.05 | 2019 | |
| Jazz Pharmaceuticals INC. | $15.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madeline Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.